Skip to main content
Journal ArticleOPEN ACCESS

Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  • Radwan I
  • Korany N
  • Ezzat B
Case Reports in Clinical Medicine (2018) 07(05) 324-342
DOI: 10.4236/crcm.2018.75030
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Radwan, I. A., Korany, N. S., & Ezzat, B. A. (2018). Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis. Case Reports in Clinical Medicine, 07(05), 324–342. https://doi.org/10.4236/crcm.2018.75030

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

67%

Researcher 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

67%

Pharmacology, Toxicology and Pharmaceut... 1

33%

Save time finding and organizing research with Mendeley

Sign up for free